PUBLISHER: The Business Research Company | PRODUCT CODE: 1270555
PUBLISHER: The Business Research Company | PRODUCT CODE: 1270555
“Temperature Controlled Pharmaceutical Containers Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on temperature controlled pharmaceutical containers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for temperature controlled pharmaceutical containers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The temperature controlled pharmaceutical containers market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Major players in the temperature controlled pharmaceutical containers market are Peli BioThermal, Sonoco Company, Cryopak, Cold Chain Technologies Inc., Envirotainer Ltd., Sofrigam, Inmark LLC, Va Q Tec AG, Tempack Packaging Solutions SL, Intelsius UK, American Aerogel Corporation, FedEx Corporation, United Parcel Service of America Inc., Amerisourcebergen Corporation, and Snyder Industries LLC.
The global temperature controlled pharmaceutical containers market is expected to grow from $5.00 billion in 2022 to $5.52 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The temperature controlled pharmaceutical containers market is expected to grow to $8.18 billion in 2027 at a CAGR of 10.3%.
The temperature controlled pharmaceutical containers market consists of sales of single-use, and reusable temperature-controlled pharmaceutical containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Temperature-controlled pharmaceutical containers refer to containers that are accessed with sensors to protect the contents they can detect minute temperature changes and even discern if the materials get exposed to light, which could contaminate the products. It is used to maintain product integrity and avoid contamination.
North America was the largest region in the temperature controlled pharmaceutical containers market in 2022. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature controlled pharmaceutical containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The controls involved in temperature controlled pharmaceutical containers are active and passive. Active shipping containers are typically leased and integrated with modern temperature controls that are frequently powered by electricity and/or featured with batteries. The various form involved are chest style and upright style which is of vaccines or drugs (IV), samples (blood, biopsy, etc.), reagents, and genetic materials content. They are used by pharmaceutical and clinical trial end users.
Increasing sales of vaccines are driving the demand for the temperature-controlled pharmaceutical containers market, going forward. Vaccines are medication employed to boost the body's immunological defenses against diseases, enabling it to combat an infection that has never been encountered before as well as intended to prevent disease rather than to treat it. Vaccines and other temperature-sensitive goods must be stored and transported in temperature-controlled containers for safety. For an instance, in March 2022, according to the annual report published by Sanofi S.A, a France-based biopharmaceutical and healthcare company, the vaccines segment recorded net revenue of USD 6,197.96 million in 2021 and USD 58,548.8 million in 2020, recording an increase of 6.8% CER and 5.9%, reported basis, which included growth across all franchises. Therefore, an increasing sale of vaccines will drive the growth of the temperature-controlled pharmaceutical container market.
Innovation and development of novel packaging solutions are a key trend gaining popularity in the temperature-controlled pharmaceutical containers market. Major players in the temperature-controlled pharmaceutical containers sector are focused on innovation and the development of novel packaging solutions to sustain their marketplace. For an instance, in March 2022, Tower Cold Chain, a UK-based company, engaged in packaging and container manufacturing, launched the KTEvolution container for the transportation of pharma, life sciences, and biomedical products under temperature control. Compact vacuum-insulated panels with phase-change technology were used in the KTEvolution container to enable long-term thermal protection without the need for human intervention. KTEvolution uses a few fasteners and fittings to achieve innovation, particularly a lightweight webbing system that wraps around the container's exterior body.
In December 2021, CSafe Global, a US-based company engaged in thermal shipping solutions acquired Softbox Systems for an undisclosed amount. With this acquisition, Csafe will become the go-to provider for the cold chain delivery of expensive, temperature-sensitive pharmaceutical medicines. Softbox Systems is a UK-based company that offers passive temperature-controlled packaging solutions for the pharmaceutical, life sciences, and cold chain logistics industries.
The countries covered in the temperature controlled pharmaceutical containers market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The temperature controlled pharmaceutical containers market research report is one of a series of new reports from The Business Research Company that provides temperature controlled pharmaceutical containers market statistics, including temperature controlled pharmaceutical containers industry global market size, regional shares, competitors with temperature controlled pharmaceutical containers market share, detailed temperature controlled pharmaceutical containers market segments, market trends, and opportunities, and any further data you may need to thrive in the temperature controlled pharmaceutical containers industry. This temperature controlled pharmaceutical containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.